# FDA recall D-0577-2020

> **Pfizer Inc.** · Class II · drug recall initiated 2019-11-27.

## Product

25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10

## Reason for recall

Labeling: Incorrect  or Missing Lot and/or expiration date.

## Distribution

Nationwide within the United States including Puerto Rico.

## Key facts

- **Recall number:** D-0577-2020
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-11-27
- **Report date:** 2019-12-18
- **Termination date:** 2022-01-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0577-2020

## Citation

> AI Analytics. FDA recall D-0577-2020. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0577-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*